A structured analysis of the evidence confirms that infection with mosquito-borne Zika virus is a cause of the neurological disorder Guillain-Barre Syndrome (GBS), in addition to microcephaly and other congenital brain abnormalities, according to a systematic review published in PLOS Medicine by Nicola Low of the University of Bern, Switzerland, and colleagues in the World Health Organization (WHO) Zika Causality Working Group.
In March 2016, WHO stated that there was a strong scientific consensus that Zika virus is a cause of GBS, microcephaly, and other neurological disorders. However, decisions about causality must be assessed systematically to guide public health actions. In the new work, the WHO group defined specific questions about the relationship between Zika virus and clinical outcomes, setting a framework of ten dimensions to define causality. They then reviewed existing literature for studies that addressed the outcomes–either GBS or congenital brain abnormalities–and convened a panel of experts to assess the review findings.
Based on 72 studies published up to May 30, 2016, that included data on Zika and congenital brain abnormalities, the team concluded that at least eight of the ten criteria for causality were met. Based on 36 studies published in the same time frame with data on Zika and GBS, the researchers concluded that at least seven of the ten criteria for causality were met. In addition, papers published after the initial literature review–between May 30 and July 29, 2016–strengthened the initial findings that Zika virus is causative of brain abnormalities and GBS. However, there are remaining questions about the link that will need to be addressed with continuing studies.
"Rapid and systematic reviews with frequent updating and open disseminating are now needed, both for appraisal of the evidence about Zika virus infection and for the next public health threats that will emerge," the authors say. "This rapid systematic review found sufficient evidence to conclude that Zika virus is a cause of congenital abnormalities and is a trigger of GBS."
###
Research Article
Funding:
The review was funded by the World Health Organization (http://www.who.int, contract numbers 2016/611294-0 and 2016/630126-0 awarded to NL) and the Swiss National Science Foundation (http://www.snf.ch, SNSF special action fund and project grant 320030_170069 awarded to NL). The following World Health Organization staff are coauthors of the study: LR, OTO, and NJB. They were involved in the study design, data interpretation, decision to publish, and preparation of the manuscript. The WHO Zika Causality Working Group was involved in interpretation of the data and the decision to publish.
Competing Interests:
I have read the journal's policy and the authors of this manuscript have the following competing interests: NL receives a stipend as a specialty consulting editor for PLOS Medicine and serves on the journal's editorial board. FK and MR received salary support from WHO and/or SNSF to conduct the work. RMV was a consultant of PAHO. All other authors have declared that no competing interests exist.
Citation:
Krauer F, Riesen M, Reveiz L, Oladapo OT, Martínez-Vega R, Porgo TV, et al. (2017) Zika Virus Infection as a Cause of Congenital Brain Abnormalities and Guillain-Barré Syndrome: Systematic Review. PLoS Med 14(1): e1002203. doi:10.1371/journal.pmed.1002203
Author Affiliations:
Institute of Social and Preventive Medicine, University of Bern, Switzerland
Pan American Health Organization, Washington, District of Columbia, United States of America
UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland
Escuela de Microbiologia, Universidad Industrial de Santander, Santander, Colombia
Department of Social and Preventative Medicine, Laval University, Québec, Canada
IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER:
http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002203
Media Contact
PLOS Medicine
[email protected]
############
Story Source: Materials provided by Scienmag